1Cooper ME.Pathogenesis,prevention and treatment of diabetic nephropathy.Lancet,1998,352:213-219.
2Chappey O,Dossquet C,Wautier MP,et al.Advanced glyca tion end products,oxidant stress and vascular lesions.Eur J Clin Invest,1997,27 :97-108.
3Nishikama T,Edelstein D.Brownlee M.The missing link:a single unifying mechanism for diabetic complications.Kidney lnt,2000,77(suppl):S26 S30.
4Kumar A,Hawkins KS,Hannan M A,et al.Activation of PKC beta(I)iu glomerular mesangial cells is associated with specific NF-kappaB subunit translocation.Am J Physiol Renal Physiol,2001,281 :F613-F619.
5Ha H,Yu MR,Choi YJ,et al.Role of high glucose-induced uuclear factor-kappaB activation in monocyte chemoattractant protein 1 expression by rnesangial cells.J Am Soc Nephrol,2002,13:894-902.
6Banba N,Nakamura T,Matsumura M,et al.Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.Kidney Int,2000,58:684-690.
8Heidland A,Sebekova K,Schinzel R.Advanced glycation end products and the progressive course of renal disease.Am J Kidney Dis,2001,38(4 Suppl 1):S100-S106.
9Hofmann MA,Schiekofer S,Isermann B,et al.Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-κB.Diabetologia,1999,42:222-232.
9Wada T,Furuichi K,Sakai N,et al.Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy[J].Kidney Int,2000,58(4)1492-1499.
10Kodama N,Otani H,Yamada Y,et al.Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats[J].Kidney Int Suppl,1999,71(5):174-177.
